Filing Details
- Accession Number:
- 0000078003-23-000052
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-03-23 16:14:26
- Reporting Period:
- 2023-03-17
- Accepted Time:
- 2023-03-23 16:14:26
- Original Submission Date:
- 2023-03-21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1782223 | Pyxis Oncology Inc. | PYXS | Pharmaceutical Preparations (2834) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
78003 | Pfizer Inc | 66 Hudson Boulevard East New York NY 10001-2192 | No | No | Yes | No | |
1776087 | Pfizer Ventures (Us) Llc | 66 Hudson Boulevard East New York NY 10001-2192 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2023-03-17 | 1,811,594 | $2.76 | 5,952,263 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The securities were issued under that certain first amendment dated March 16, 2023 to the Amended and Restated License Agreement dated October 14, 2022 between the Reporting Person and the Issuer, pursuant to which the Issuer agreed to issue to the Reporting Person such number of shares of common stock equivalent to $5.0 million at a per share price equal to the closing price of the Issuer's common stock on the business day when the closing price of the Issuer's common stock on the Nasdaq Global Select Market is at or above $2.46 per share on any day between March 16, 2023 and a date that is within 180 days following October 6, 2022.
- On March 17, 2023, the closing price of the Issuer's common stock on the Nasdaq Global Select Market was $2.76 per share.